imply alternative splicing mechanisms suppressing the effect of the stop mutation in some tissues. Contrasting with these reports, we present the second case of a child homozygous for G542X with severe pancreatic and lung disease. Another similar finding has just been reported in a Turkish boy in the neonatal period by Bienvenu et al. "3 Such contradictions in genotype/phenotype correlations might be resolved in the future by mRNA and protein expression studies in target tissues.
We wish to express our gratitude to the Association Francaise de Lutte contre la Mucoviscidose (AFLM). The manuscript was typed by T Bousquet. (5) Apparent reduced penetrance may partly be the result of ascertainment bias, since in most of the studies undertaken, short stature and x ray abnormalities were the main criteria for diagnosis.2' But, in addition, variable expression, although uncommon in most AR disorders, may also cause a low segregation ratio. The occurrence of mild immunodeficiency without dwarfism has been described in CHH.7 However, in most studies only short statured CHH patients have been checked for immunodeficiency,'4 with the exception of one in which sibs were used as controls.' Therefore CHH patients with only mild immunodeficiency could have been missed, thereby skewing the number of affected sibs.
MARIE DESGEORGES
The well known increased risk of intrauterine lethality in several AR disorders, though not in CHH,' can be considered to be the most severe end of this spectrum of variability. Also the intrafamilial heterogeneity of cystic fibrosis, perhaps because of other modifying loci,9 makes it plausible that
